Stimate

Generic name: desmopressin

Used for: Bleeding in mild hemophilia A · Bleeding in mild to moderate von Willebrand disease (type 1) · 1 more

How do you pay?

How to pay the least

Ask for the cash price

Stimate

Sold only in a different form, strength or formula. Switching to one would need a new prescription, so ask your prescriber whether it could work for you.

  1. Ask your pharmacy for Stimate’s cash price, and one or two other pharmacies too.

Compare every option

Question
Brand nameStimate
Authorized genericdesmopressin
Regular genericdesmopressin
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Other forms onlyAsk your doctor
Same as Stimate?
The original
–
–

Brand nameNo maker’s card

We didn’t find a savings card or cash price from Stimate’s maker. Ask the pharmacy for Stimate’s cash price. With insurance, ask what your plan charges.

Authorized genericNot sold

There isn’t one. An authorized generic is Stimate itself, from the same company, sold without the brand name, and usually for less. For now Stimate is the only choice; ask the pharmacy for its cash price, or your plan what it charges.

Regular genericNot sold

Sold only in a different form, strength or formula. Switching to one would need a new prescription, so ask your prescriber whether it could work for you. Generics usually come once the brand’s patents and exclusivity end. Until then, ask the pharmacy for Stimate’s cash price, or your plan what it charges.

What it’s used for

What the FDA label says

STIMATE is a vasopressin analog used for:

  • Hemophilia A - for patients with factor VIII coagulant activity levels greater than 5% to maintain hemostasis during surgical procedures and postoperatively or reduce bleeding with episodes of spontaneous or traumatic injuries such as hemarthroses, intramuscular hematomas, or mucosal bleeding.
  • von Willebrand’s disease (Type I) - for patients with mild to moderate disease with factor VIII levels greater than 5% to maintain hemostasis during surgical procedures or traumatic injuries such as hemarthroses, intramuscular hematomas, or mucosal bleeding.

Limitations of Use

STIMATE is not indicated for:

  • von Willebrand’s disease (severe Type I) - not indicated for the treatment of patients with severe Type I von Willebrand’s disease and when there is evidence of an abnormal molecular form of factor VIII antigen.

Source: the FDA label for Stimate (Ferring Pharmaceuticals Inc.), July 22, 2026. Full label on DailyMed 

Good to know

Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/stimate/